Insights

Loading spinner
Gathering insights about Ernexa Therapeutics

Ernexa Therapeutics Tech Stack

Ernexa Therapeutics uses 8 technology products and services including Webpack, Microsoft 365, Next.js, and more. Explore Ernexa Therapeutics's tech stack below.

  • Webpack
    Development
  • Microsoft 365
    Email
  • Next.js
    Javascript Frameworks
  • PWA
    Miscellaneous
  • Priority Hints
    Performance
  • Vercel
    Platform As A Service
  • Node.js
    Programming Languages
  • HSTS
    Security

Ernexa Therapeutics's Email Address Formats

Ernexa Therapeutics uses at least 2 format(s):
Ernexa Therapeutics Email FormatsExamplePercentage
FLast@brooklynitx.comJDoe@brooklynitx.com
97%
FiLast@brooklynitx.comJoDoe@brooklynitx.com
3%
First.Last@ernexatx.comJohn.Doe@ernexatx.com
100%

Frequently Asked Questions

What is Ernexa Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Ernexa Therapeutics is a publicly traded company; the company's stock symbol is ERNA.

What is Ernexa Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Ernexa Therapeutics's official website is ernexatx.com and has social profiles on LinkedIn.

What is Ernexa Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Ernexa Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Ernexa Therapeutics have currently?

Minus sign iconPlus sign icon
As of December 2025, Ernexa Therapeutics has approximately 11 employees across 1 continents, including North America. Key team members include Chief Development Officer: R. G.Vice President Of Finance: S. G.President & Ceo: S. L.. Explore Ernexa Therapeutics's employee directory with LeadIQ.

What industry does Ernexa Therapeutics belong to?

Minus sign iconPlus sign icon
Ernexa Therapeutics operates in the Biotechnology Research industry.

What technology does Ernexa Therapeutics use?

Minus sign iconPlus sign icon
Ernexa Therapeutics's tech stack includes WebpackMicrosoft 365Next.jsPWAPriority HintsVercelNode.jsHSTS.

What is Ernexa Therapeutics's email format?

Minus sign iconPlus sign icon
Ernexa Therapeutics's email format typically follows the pattern of FLast@brooklynitx.com. Find more Ernexa Therapeutics email formats with LeadIQ.

When was Ernexa Therapeutics founded?

Minus sign iconPlus sign icon
Ernexa Therapeutics was founded in 1994.

Ernexa Therapeutics

Biotechnology ResearchMassachusetts, United States11-50 Employees

Ernexa Therapeutics (NASDAQ: ERNA) is developing innovative stem cell therapies for the treatment of advanced cancer and autoimmune diseases. Ernexa’s core technology focuses on engineering induced pluripotent stem cells (iPSCs) and transforming them into induced mesenchymal stem cells (iMSCs). Ernexa’s allogeneic synthetic iMSCs provide a scalable, off-the-shelf treatment solution, without needing patient-specific cell harvesting.

Section iconCompany Overview

SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
ERNA
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1994
Employees
11-50

Section iconFunding & Financials

  • $1M$10M

    Ernexa Therapeutics's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Ernexa Therapeutics's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.